ALAMEDA, Calif. (AP) _ OncoCyte Corp. (OCX) on Monday reported a loss of $4.5 million in its fourth quarter.
The Alameda, California-based company said it had a loss of 11 cents per share.
For the year, the company reported that its loss narrowed to $15.8 million, or 42 cents per share.
In the final minutes of trading on Monday, the company's shares hit $4.29. A year ago, they were trading at $2.25.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCX at https://www.zacks.com/ap/OCX